A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

Ovarian cancer, known as the silent killer, often presents with vague symptoms like bloating, frequent urination, and fatigue. Risk factors include family history and certain genetic mutations.

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women ...

A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new study. This was the case for Nefa-Tari Moore, 45, a three time "thriver" of ...

Black and American Indian patients are less likely to have elevated CA-125 levels compared with White patients.

Acrivon Therapeutics is halting work on developing its lead drug for ovarian and bladder cancers, instead focusing the Eli ...

Mural Oncology ends nemvaleukin development for ovarian cancer after ARTISTRY-7 trial misses survival goals. Phase 2 trials ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

Mural Oncology said that it won't continue developing its ovarian cancer drug candidate Nemvaleukin to be used in conjunction with Merck's Keytruda after results showed no statistical improvement in ...

Sanford Health’s Bloom the Boutique helps well over a dozen cancer patients each month get a new wig. But it’s not everyday ...

Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...